Ignite Creation Date:
2024-05-06 @ 2:30 PM
Last Modification Date:
2024-10-26 @ 1:32 PM
Study NCT ID:
NCT04337931
Status:
TERMINATED
Last Update Posted:
2024-02-13
First Post:
2020-03-30
Brief Title:
A Study to Evaluate Sotigalimab APX005M in Subjects With Unresectable or Metastatic Melanoma
Sponsor:
Apexigen America Inc
Organization:
Apexigen America Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-12
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-02
Completion Date Type:
ACTUAL
First Submit Date:
2020-03-30
First Submit QC Date:
April 6 2020
Study First Post Date:
2020-04-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-12-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2023-07-18
Disp First Submit QC Date:
August 29 2023
Disp First Post Date:
2023-09-01
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-01-18
Last Update Post Date:
2024-02-13
Last Update Post Date Type:
ACTUAL